Literature DB >> 9620350

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection.

G Ostapowicz1, K J Watson, S A Locarnini, P V Desmond.   

Abstract

In patients with chronic hepatitis C, alcohol consumption has been proposed as a risk factor for the progression of liver disease; however, evidence for this remains conflicting. Two hundred thirty-four anti-hepatitis C virus (HCV)-positive patients who had a liver biopsy performed within the past 24 months were studied. Demographic data and information on risk factors were recorded. A detailed lifetime alcohol consumption history was obtained. Viral studies included HCV viral titer and HCV genotype. Mean age (+/- SEM) of the group was 40.8 +/- 0.7 years. One hundred sixty-six (71%) were male. A risk factor for HCV infection was found in 195 patients (86%). Genotype distribution was: 1b: 22%; 1a: 15%; 1(nonsubtypable): 15%; 3a: 34%; and 2: 7%. Fifty (21%) patients had cirrhosis. Patients with cirrhosis were older (51.6 +/- 1.8 years) than those with chronic hepatitis (37.6 +/- 0.6 years; P = .0001), were infected at an older age (25.9 +/- 2.0 vs. 20.9 +/- 0.6 years; P = .001), and had a longer duration of infection (20.5 +/- 1.3 vs. 16.2 +/- 0.5 years; P = .0008). Patients with cirrhosis had a greater total lifetime alcohol consumption (288,765 +/- 58,115 g) than those with chronic hepatitis (189,941 +/- 15,453 g; P = .018). Cirrhotic patients also had greater total alcohol consumption during the period of infection with HCV (240,962 +/- 63,756 g vs. 146,510 +/- 12,862 g; P = .02). On multivariate analysis, subject age and total alcohol consumption were independently associated with the presence of cirrhosis. Total lifetime alcohol consumption is a risk factor for the progression of liver disease caused by HCV.

Entities:  

Mesh:

Year:  1998        PMID: 9620350     DOI: 10.1002/hep.510270637

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  55 in total

1.  Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study.

Authors:  A R Osella; L Sonzogni; A Cavallini; L Foti; V Guerra; A Di Leo; M U Mondelli; G Misciagna; E M Silini
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics.

Authors:  Vivekananda Shetty; Pooja Jain; Zacharie Nickens; Gomathinayagam Sinnathamby; Anand Mehta; Ramila Philip
Journal:  OMICS       Date:  2011-10

3.  Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells.

Authors:  Gavin E Arteel
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

Review 4.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

5.  Problem alcohol use among problem drug users: development and content of clinical guidelines for general practice.

Authors:  J Klimas; W Cullen; C-A Field
Journal:  Ir J Med Sci       Date:  2013-07-03       Impact factor: 1.568

6.  Hepatitis C virus risk factors in the Turkish community.

Authors:  Beytullah Yildirim; Veysel Tahan; Resat Ozaras; Huseyin Aytekin; Ali Mert; Fehmi Tabak; Hakan Senturk
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

Authors:  T Spelman; M D Morris; G Zang; T Rice; K Page; L Maher; A Lloyd; J Grebely; G J Dore; A Y Kim; N H Shoukry; M Hellard; J Bruneau
Journal:  J Epidemiol Community Health       Date:  2015-03-26       Impact factor: 3.710

8.  Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

Authors:  Ashwin Balagopal; Frances H Philp; Jacquie Astemborski; Timothy M Block; Anand Mehta; Ronald Long; Gregory D Kirk; Shruti H Mehta; Andrea L Cox; David L Thomas; Stuart C Ray
Journal:  Gastroenterology       Date:  2008-03-29       Impact factor: 22.682

9.  Alterations in Serum Zinc and Polyunsaturated Fatty Acid Concentrations in Treatment-Naive HIV-Diagnosed Alcohol-Dependent Subjects with Liver Injury.

Authors:  Vatsalya Vatsalya; Matthew C Cave; Rajarshi Kumar; Shweta Srivastava; Sujita Khanal; Alfred B Jenson; Melanie L Schwandt; Shirish S Barve; Vijay A Ramchandani; Craig J McClain
Journal:  AIDS Res Hum Retroviruses       Date:  2018-12-11       Impact factor: 2.205

10.  Prevalence of problem alcohol use among patients attending primary care for methadone treatment.

Authors:  Niamh Ryder; Walter Cullen; Joseph Barry; Gerard Bury; Eamon Keenan; Bobby P Smyth
Journal:  BMC Fam Pract       Date:  2009-06-11       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.